Transplantation Updates
Just Released - Transplantation - April 2023 Issue
Around the World
Research Highlights
Game Changer
People in Transplantation
Special Article
Meeting Report
Commentaries
- Simultaneous Pancreas-kidney Transplantation Candidates With Type 2 Diabetes Mellitus: Elevated C-peptide Levels Warrant Scrutiny, May Portend Worse Outcomes
- Is ABO Compatibility Important in Islet Transplantation?
- Assessing the Reversibility of Renal Impairment in Patients Awaiting Heart Transplantation
- Many a Slip Twixt the Intake Form and the Living Donation
- Clinical Integration of Genomic Testing in Kidney Transplantation Clinics
- When the Guest Meets the Host: Assessing the Immune Reconstitution of the Liver Graft One Cell at a Time
- Preexisting Coronary Artery Disease in Liver Transplant Candidates: Risk Factor or Risk Marker?
Reviews
- Pathways of Antigen Recognition by T Cells in Allograft Rejection
- Health-related Quality of Life Outcomes Following Single or Bilateral Lung Transplantation: A Systematic Review
- Liver Paired Exchange: Programmatic Hopes and Fears
- Balancing the Risks and Benefits of Pet Ownership in Pediatric Transplant Recipients
- Addressing Risks Derived From the Commodification of Substances of Human Origin: A European Proposal Applicable Worldwide
Original Basic Science
- Renal Ischemia–reperfusion Injury Attenuated by Exosomes Extracted From Splenic Ischemic Preconditioning Models
- Evaluating the Potential for ABO-incompatible Islet Transplantation: Expression of ABH Antigens on Human Pancreata, Isolated Islets, and Embryonic Stem Cell-derived Islets
- Transcription Factor YY1 Ameliorates Liver Ischemia-reperfusion Injury Through Modulating the miR-181a-5p/ESR1/ERBB2 Axis
- Decoding Single-cell Landscape and Intercellular Crosstalk in the Transplanted Liver
- Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies
Original Clinical Science—Liver
- Clinical Impact of Spontaneous Portosystemic Shunts in Liver Transplantation: A Comprehensive Assessment Through Total Shunt Area Measurement
- Utility of Digital Single-operator Video Cholangioscopy for the Endoscopic Management of Biliary Complications After Liver Transplantation—A Single-center Experience
- Outcomes of Liver Transplantation in Patients With Preexisting Coronary Artery Disease
Original Clinical Science—General
- Higher Fasting Pretransplant C-peptide Levels in Type 2 Diabetics Undergoing Simultaneous Pancreas-kidney Transplantation Are Associated With Posttransplant Pancreatic Graft Dysfunction
- Characteristics of Potential and Actual Living Kidney Donors: A Single-center Experience
- Incorporation of Genetic Studies in the Kidney Transplant Evaluation Clinic: The Value of a Multidisciplinary Approach
- The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients
- Financial Impact of a Culturally Sensitive Hispanic Kidney Transplant Program on Increasing Living Donation
- Severely Reduced Kidney Function Assessed by a Single eGFR Determination at the Time of an Isolated Heart Transplant Does Not Predict Inevitable Posttransplant ESKD
- Increasing Proportion of High-risk Cytomegalovirus Donor-positive/Recipient-negative Serostatus in Solid Organ Transplant Recipients
- Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome
Letters to the Editor
Transplantation - Highlighted Tweets
Thrombotic microangiopathy (TMA) is a rare and devastating complication of kidney transplantation, which often leads to graft failure. Posttransplant TMA (PT-TMA) may occur either de novo or as a recurrence of the disease. De novo TMA can be triggered by immunosuppressant drugs, antibody-mediated rejection, viral infections, and ischemia/reperfusion injury in patients with no evidence of the disease before transplantation. Recurrent TMA may occur in the kidney grafts of patients with a history of atypical hemolytic uremic syndrome (aHUS) in the native kidneys.
Trifecta (ClinicalTrials.gov #NCT04239703) is a prospective trial defining relationships between donor-derived cell-free DNA (dd-cfDNA), donor-specific antibody (DSA), and molecular findings in kidney transplant biopsies. Previous analyses of double results showed dd-cfDNA was strongly associated with rejection-associated molecules in the biopsy. The present study analyzed the triple results in 280 biopsies, focusing on the question of dd-cfDNA levels in DSA-negative antibody-mediated rejection (AMR).
Transplantation Direct - Highlighted Tweet
Normothermic regional perfusion (NRP) has gained widespread adoption in multiple European countries. The aim of this study was to examine the influence of thoracoabdominal-NRP (TA-NRP) on the utilization and outcomes of liver, kidney, and pancreas transplantation in the United States.
Following the outbreak of coronavirus disease 2019 (COVID-19) in the United States, the number of kidney waitlist additions and living-donor and deceased-donor kidney transplants (LDKT/DDKT) decreased substantially but began recovering within a few months. Since then, there have been several additional waves of infection, most notably, the Delta and Omicron surges beginning in August and December 2021, respectively.
2023 Organ Donation Congress (ISODP 2023)
Register Today for ITS 2023!
The hotel is almost sold out! Book your room ASAP!
Announcement - 41st Annual Scientific meeting (ASM) of TSANZ
Dear Colleagues,
We are delighted to announce and invite you to “save the date” for the 41st Annual Scientific meeting (ASM) of the Transplantation Society of Australia and New Zealand (TSANZ) which will be held from Sunday 18 – Tuesday 20th June 2023 at the Brisbane Convention and Exhibition Centre in beautiful and sunny Brisbane, Queensland.
The TSANZ Scientific Program and Education Committee (SPEC), in conjunction with the TSANZ Council, have prepared an exciting program convened by Dr Chandima Divithotawela and A/Professor Antiopi Varelias.
This year's program features Plenary sessions from several renowned international speakers on recent advances in the areas of transplant immunology, xenotransplantation, emerging cellular therapies, chronic rejection and organ donation. Not limited to this, the program will also span transplant genetics, cutting-edge basic science topics, ethical issues of transplantation and will include a Women in Transplant (WIT) session.
As with previous years, this year, we are delighted to host three pre-ASM sessions including:
- an HLA Day on Friday 16th June (convened by Dr Lucy Sullivan and Rhonda Holdsworth)
- the Postgraduate Course on Saturday 17th June (convened by Dr Jennifer Li and Dr Handoo Rhee)
- the Masterclass on Sunday 18th June (convened by Steven Hiho and Dr Georgina Irish).
The annual Awards dinner with live entertainment will be held in the iconic Brisbane City Hall, a short stroll along the Victoria Bridge over the stunning Brisbane River. Besides networking opportunities, several social events are planned by the TSANZ Early Career Researcher Committee (ECRC) including:
- the annual Fun Run
- Early Career researchers' drinks after the PGC on Saturday
- “Meet a Researcher” event
We look forward to welcoming you to Australia’s River City in June 2023 for what will be an exceptional and exciting meeting!
TSANZ ia an Affiliated Society of TTS
IPITA-IXA-CTRMS 2023 Joint Congress
Upcoming Meeting Announcements
TTS 2024
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada